AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papakonstantinou, O.
Right arrow Articles by Gourtsoyiannis, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papakonstantinou, O.
Right arrow Articles by Gourtsoyiannis, N. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 185:219-224
© American Roentgen Ray Society


Original Research

Abdominal Lymphadenopathy in ß-Thalassemia: MRI Features and Correlation with Liver Iron Overload and Posttransfusion Chronic Hepatitis C

Olympia Papakonstantinou1,2, Thomas G. Maris1, Stavroula Kostaridou3, Vasilios Ladis3, Artemis Vasiliadou4 and Nicholas C. Gourtsoyiannis1

1 Department of Radiology, MRI Unit, University Hospital of Heraklion, University of Crete Medical School, Crete, Greece.
3 First Department of Pediatrics, "Aghia Sophia" Children's Hospital, Thalassemia Unit, University of Athens, Athens, Greece.
4 Thalassemia Unit, "Aghios Georgios" Hospital, Chania, Greece.

Received May 19, 2004; accepted after revision October 4, 2004.

 
Address correspondence to O. Papakonstantinou (olypapak{at}hotmail.com).

2 Current address: Department of Radiology, Attikon Hospital, University of Athens, Rimini 1, Haidari, Athens, Greece 124 62.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. The objective of our study was to describe the MRI features of abdominal lymphadenopathy in patients with ß-thalassemia major and investigate the relation of abdominal lymphadenopathy with the severity of iron overload and posttransfusion chronic hepatitis C.

MATERIALS AND METHODS. Abdominal MRI studies of 60 consecutive patients with ß-thalassemia major, performed for quantification of liver iron overload at a single institution, were retrospectively studied for the presence of lymph nodes and their distribution, size, and number. The signal intensity ratios of liver, spleen, and the largest lymph node to the right paraspinous muscle (L/M, S/M, and LN/M, respectively) were calculated on T1-weighted gradient-echo images. MRI findings for the lymph nodes were compared with the histologically assigned activity level of chronic hepatitis C that was available in 17 patients who had undergone liver biopsy within 1 month of the MRI examination.

RESULTS. Hypointense abdominal lymph nodes larger than 7 mm were seen in 19 (32%) of 60 thalassemic patients in perihepatic and paraortic distributions. Lymphadenopathy was related to both the severity of hepatic siderosis, as expressed by the L/M values, and the presence of chronic hepatitis C, given that 18 (95%) of the 19 thalassemic patients with lymphadenopathy had chronic hepatitis C. Moreover, thalassemic patients with a moderate or severe level of hepatic inflammation presented with abdominal lymphadenopathy more frequently than those with mild hepatic inflammation.

CONCLUSION. The development of hypointense abdominal lymphadenopathy in patients with ß-thalassemia major who have received multiple transfusions depends both on the severity of liver iron overload and on the presence and the activity level of coexistent chronic hepatitis C.


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Beta-thalassemia major is a hereditary hemolytic anemia that is characterized by decreased synthesis of beta chains of hemoglobin [1]. Regular RBC transfusions result in the accumulation of excessive iron in vital organs, such as the liver, myocardium, and endocrine glands. This excess leads to organ dysfunction [2, 3], although chelation therapy has decreased the toxic effects of iron overload and increased life expectancy of thalassemic patients. Along with iron overload, posttransfusion chronic hepatitis C virus is another important complication of transfusion therapy with the prevalence of anti-hepatitis C virus antibodies exceeding 40% in patients with thalassemia [4, 5]. Liver biopsy is considered the gold standard both for the direct determination of liver iron [6] and for the confirmation of the diagnosis, grading of hepatic inflammation, and evaluation of antiviral treatment [7, 8]. However, it is an expensive and invasive procedure with inherent risks, so noninvasive methods are desirable.

During the last years, MRI has been used with increasing frequency for the noninvasive quantification of hepatic and cardiac iron overload in thalassemic patients [9-18], although a consensus in regard to the most effective MRI technique has not yet been reached. At our institution, indirect quantification of hemosiderosis of the liver and myocardium with MRI has been added in the diagnostic follow-up of thalassemic patients and has eliminated the need for liver biopsies.

We have noticed markedly hypointense perihepatic and retroperitoneal lymph nodes in several abdominal MRI studies of patients with ß-thalassemia major who were referred for evaluation of iron overload. Abdominal lymphadenopathy has been sporadically reported in patients with ß-thalassemia major, seen on abdominal radiography [19], lymphography [20], and abdominal CT [21] and more recently on sonography of the abdomen [22]. To our knowledge, the MRI findings of abdominal lymphadenopathy in ß-thalassemia major have not been described.

The goals of our study were, first, to identify the frequency of and describe the MRI findings of abdominal lymphadenopathy in a large series of patients with ß-thalassemia major who received multiple transfusions and, second, to investigate the relation between abdominal lymphadenopathy, the severity of iron overload, and the presence of posttransfusion hepatitis C in thalassemic patients.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Study Population
The MRI examinations and the medical records of 60 consecutive patients with ß-thalassemia major (22 males and 38 females) who ranged in age from 14 to 42 years (mean age, 26.8 ± 6.07 [SD] years) were retrospectively reviewed. The study protocol was approved by the board for retrospective studies of our institution. All MRI studies were performed between May 2000 and January 2003 as part of a diagnostic workup to estimate hepatic and myocardial iron overload in patients with thalassemia. All patients received systematic RBC transfusions at 2- to 3-week intervals and subcutaneous chelation with desferrioxamine. Splenectomy had been performed in 23 patients (38%). Serum ferritin levels were routinely determined in all patients every 6 months and ranged from 630 to 6,520 ng/mL (normal range, 20-200 ng/mL).

Forty-one patients had chronic hepatitis C, two of whom were also positive for HBsAg hepatitis. All patients were negative for HIV. No patient had a clinically or radiologically detectable neoplasm at the time of MRI or during the 1- or 2-year follow-up. The diagnosis of chronic hepatitis C was based on the presence of anti-hepatitis C virus antibodies and hepatitis C virus RNA in the serum and on histologic findings compatible with chronic hepatitis. All patients with chronic hepatitis C had increased serum alanine aminotransferase levels (> 80 U/L) for at least 1 year, whereas patients without hepatitis had alanine aminotransferase levels within the normal limits (25-73 U/L) or slightly above the normal range.

The pathology reports of 17 patients with hepatitis C who had undergone liver biopsy within 1 month before or after MRI were reviewed. On histology, the activity of hepatic inflammation was assessed by means of the histologic activity index, according to the criteria described by Knodell et al. [23]. The histologic activity index consists of four components: periportal necrosis with and without bridging necrosis, intralobular degeneration, portal inflammation, and fibrosis [23]. The extent of fibrosis and the development of cirrhosis were, in addition, evaluated according to Desmet et al. [24]. Subsequently, the thalassemic patients with available liver histology were categorized into two groups with regard to the activity level of chronic hepatitis: mild (n = 13 patients), moderate or severe (n = 4 patients [moderate, n =2; severe, n = 2]). The two patients with severe hepatic inflammation also had architectural changes of cirrhosis.

MRI
Technique—All examinations were performed on a 1.5-T MRI system (Vision Plus, Siemens Medical Solutions). Breath-hold gradient-echo sequences were performed using a body coil to avoid signal drop-off [18] and to ensure the highest uniformity in the signal-to-noise ratio throughout the whole scanned volume compared with the phasedarray coil. In addition, the following sequences were performed: a T1-weighted gradient-echo sequence (TR/TE, 182/4.6; flip angle, 90°) with 21 slices acquired, intermediate-weighted in-phase and out-of-phase gradient-echo sequences (120/4; flip angle, 20°; and 120/2.7; flip angle, 20°, respectively) with 15 slices acquired, and T2-weighted gradient-echo (120/15; flip angle, 20°) and T1-weighted spin-echo (600/6) sequences with 11 slices acquired. All images were obtained in the axial plane with a slice thickness of 8-10 mm, an image matrix of 256 x 192, and a field of view of 400-500 mm.

This MRI protocol is routinely used in patients with iron overload and is based on literature data [11, 12], trials with phantoms, equation fits between liver-to-muscle signal intensity ratios, and direct determination of liver iron concentration in liver biopsy specimens, so a wide spectrum of hepatic hemosiderosis can be evaluated (Papakonstantinou O and Maris TG, unpublished data).

Image interpretation—All MRI studies were retrospectively reviewed for the presence of abdominal lymphadenopathy by an experienced abdominal radiologist who was unaware of the clinical and laboratory data. All lymph nodes with a long-axis diameter equal to or greater than 8 mm were recorded and were defined as nontubular soft-tissue structures that were clearly distinguishable from adjacent anatomic structures [25]. A conservative approach was taken in the declaration of the presence of visible lymph nodes; ambiguous findings were excluded.

Lymph nodes were categorized into two major groups with regard to location: perihepatic (including periportal, peripancreatic, portacaval, celiac, and gastrohepatic) and paraortic lymph nodes in the retroperitoneum [26]. For each nodal group, the number of lymph nodes was estimated, the long and the short axes of the largest node in each group were recorded, and their size was estimated by multiplying the short axis and long axis of the node [27]. For identification of lymph nodes, images obtained with all MRI sequences were reviewed, whereas estimations of nodal number, size, and signal intensity were performed on the T1-weighted gradient-echo images, which had the best spatial resolution and depicted most conspicuously the lymph nodes over a wide spectrum of nodal signal intensities. Subsequently, the signal intensity ratios of the liver, spleen, and the largest lymph node of each nodal group to the right paraspinous muscle (L/M, S/M, and LN/M, respectively) were calculated on the same images. The signal intensity of the hepatic parenchyma was considered as the average of three signal intensity measurements obtained at circular regions of interest that measured 1-2 cm2 and were located in the right liver lobe, away from vascular structures and breathing artifacts. The signal intensity of the spleen was the average of measurements in two similar regions of interest at the periphery of the posterior segment of splenic parenchyma, whereas the signal intensity of the largest lymph node was measured in a single region of interest that was located in the central part of the node and measured 0.5-1 cm2.

Statistics
Linear regression analysis was used to correlate L/M, S/M, and LN/M ratios. To determine the impact of hepatic siderosis (i.e., L/M values), chronic hepatitis, and splenectomy on the presence of abdominal lymphadenopathy, we performed multivariable logistic analysis. The chi-square test was used for pair-wise comparisons of patients with mild hepatitis and patients with moderate or severe hepatitis in regard to the presence of abdominal lymphadenopathy, whereas the t test was used to compare nodal size and number between the two groups. All analyses were performed using statistical software (TableCurve 2D, Systat [version 7.3], MedCalc Software).


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Abdominal lymph nodes measuring 8 mm or larger were seen in 19 (32%) of the 60 patients. Lymph nodes were seen in perihilar distribution in all 19 patients (100%) and in paraortic distribution in 14 (74%) of the 19 patients with abdominal lymphadenopathy. The maximum size of the perihepatic lymph nodes was 540 mm2 (mean, 221.4 ± 110.7 [SD] mm2), with a maximum long axis of 27 mm and maximum short axis of 20 mm. For the paraortic lymph nodes, the maximum size was 667 mm2 (mean, 251.2 ± 158.9 mm2), with a maximum long axis of 29 mm and maximum short axis of 23 mm. The maximum number of perihepatic lymph nodes was 12 (mean, 4.8 ± 2.8) and of the paraortic ones, 10 (mean, 5.5 ± 2.4).



View larger version (113K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A 29-year-old woman with ß-thalassemia, severe iron overload (serum ferritin, 5,300 ng/mL), and mild level of activity of chronic hepatitis C. T1-weighted gradient-echo image shows multiple hypointense perihepatic lymph nodes (arrows). Both liver and spleen are markedly hypointense with signal intensities equal to background noise.

 



View larger version (112K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B 29-year-old woman with ß-thalassemia, severe iron overload (serum ferritin, 5,300 ng/mL), and mild level of activity of chronic hepatitis C. T1-weighted gradient-echo image shows paraortic lymph node is in caudal section (arrow), with signal equal to background noise. Lymph node-to-muscle signal intensity (SI) ratio is 0.08; liver-to-muscle SI ratio, 0.045; and spleen-to-muscle SI ratio, 0.07.

 



View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 26-year-old man with ß-thalassemia and severe iron overload (serum ferritin, 3,200 ng/mL). T1-weighted gradient-echo image shows hypointense lymph nodes at porta hepatis (arrow) with signal intensities equal to that of liver. Spleen is enlarged but is less hypointense than liver—that is, with less iron deposition. Lymph node-to-muscle signal intensity (SI) ratio is 0.06; liver-to-muscle SI ratio, 0.055; and spleen-to-muscle SI ratio, 0.64.

 



View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 34-year-old woman with ß-thalassemia, moderate iron overload (serum ferritin, 1,120 ng/mL), and severe activity of hepatic inflammation with histologic findings of hepatic cirrhosis; patient underwent splenectomy 16 years earlier. T1-weighted gradient-echo image shows multiple enlarged and hypointense perihepatic lymph nodes (arrows). Both liver and lymph nodes are moderately hypointense. Lymph node-to-muscle signal intensity (SI) ratio is 0.73 and liver-to-muscle SI ratio is 0.77.

 
Both perihepatic and paraortic lymph nodes were homogeneously hypointense, and their signal intensities were close to that of liver, as seen on visual inspection (Figs. 1A, 1B, 2, 3) and proved by the close correlation of LN/M and L/M values (r = 0.83, p < 0.0001) (Fig. 4). The degree of iron deposition in the spleen, as expressed by the S/M values, did not correlate with either L/M or LN/M values (r = 0.26, p = 0.49 and r = 0.20, p = 0.61, respectively).



View larger version (17K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 Graph shows correlation between liver-to-muscle and lymph node-to-muscle signal intensity ratios on T1-weighted gradient-echo sequence (TR/TE, 182/4.6; flip angle, 90°) for 19 thalassemic patients with abdominal lymphadenopathy (r =0.83, p < 0001).

 
Multivariable logistic regression analysis revealed that the presence of lymphadenopathy was related both to the presence of chronic hepatitis (p = 0.025) and to the degree of hepatic iron overload, as expressed by the L/M ratios (p = 0.009). We find it note-worthy that 18 (95%) of our 19 thalassemic patients with abdominal lymphadenopathy on MRI were positive for hepatitis C, whereas 18 (44%) of the 41 hepatitis C-positive patients with thalassemia developed lymphadenopathy. Moreover, thalassemic patients with abdominal lymphadenopathy had higher levels of hepatic siderosis, as shown by the lower L/M values, compared with patients without lymphadenopathy. Splenectomy was not related to the presence of lymphadenopathy in a statistically significant degree. Table 1 shows the differences between patients with and those without abdominal lymphadenopathy with regard to L/M ratios, hepatitis C status, and splenectomy.


View this table:
[in this window]
[in a new window]

 
TABLE 1 : Liver-to-Muscle Signal Intensity Ratios, Frequency of Chronic Hepatitis C, and Frequency of Splenectomy in Thalassemic Patients With and Without Abdominal Lymphadenopathy

 

Of the 60 thalassemic patients in our study group, 41 were positive for the hepatitis C virus; in 17 of these 41 patients with hepatitis C, liver histology results obtained within 1 month from the time of MRI were available. According to the histologic report, 13 of the 17 patients had mild level of activity of hepatic inflammation and the remaining four patients had moderate or severe level of activity. For this group of 17 thalassemic patients with hepatitis C and available liver histology, we considered the relation between the activity level of chronic hepatitis and the development of abdominal lymphadenopathy.

We found that the presence of lymphadenopathy was related to the activity level of chronic hepatitis C (p < 0.05) for the 17 thalassemic patients with available evaluation of the level of hepatic inflammation on histology. As shown in Table 2, of the 13 patients with histologically confirmed mild activity of hepatic inflammation, only four developed abdominal lymphadenopathy. Nodes were seen in all four patients with moderate or severe level of activity of hepatic inflammation. In addition, patients with moderate or severe level of activity of hepatic inflammation had larger mean size and higher mean number of affected lymph nodes than patients with mild activity of hepatitis, but pair-wise comparison was significant only for nodal size. Table 2 summarizes the results regarding the presence of lymphadenopathy and the number and size of lymph nodes with respect to the activity level of chronic hepatitis.


View this table:
[in this window]
[in a new window]

 
TABLE 2 : Presence, Number, and Size of Lymph Nodes with Regard to the Activity Level of Chronic Hepatitis C in 17 Thalassemic Patients with Available Liver Histology

 


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Abdominal lymphadenopathy in patients with ß-thalassemia major was recognized initially by surgeons who performed therapeutic splenectomies [1]; however, radiologic descriptions of iron-laden lymph nodes are scarce. Winchester et al. [19] reported the radiologic appearance of enlarged lymph nodes in four patients with thalassemia major as elongated nodular densities in a chainlike fashion bilaterally that were visualized along the upper lumbar and lower thoracic spine [19]. Mitnick et al. [21] reported striking hyperdensity of enlarged abdominal lymph nodes on CT in nine thalassemic patients who were receiving a hypertransfusion regimen. On histology, these hyperdense nodes displayed heavy deposition of iron pigment in expanded cortical and medullary sinusoids, with sparing of cortical follicles [21], a description that may conform to reactive hyperplasia with iron accumulation in the reticuloendothelial cells of the hyperplastic node.

Parsons [20] referred to lymphographic patterns of enlarged paraortic and iliac lymph nodes that ranged from coarsely granular nodes to large filling defects. In a more recent study, Chu et al. [22] reported enlargement of lymph nodes at the hepatoduodenal ligament on sonography in 12 (32.4%) of 37 consecutive thalassemic patients. The latter authors did not specify whether they searched for retroperitoneal lymphadenopathy [22]; detection of lymph nodes in the ventral portion of the hepatoduodenal ligament and retroperitoneum may be difficult on sonography [27, 28] because of the surrounding fat and connective tissue.

We found a similar frequency of abdominal lymphadenopathy (32%) in a larger series of 60 consecutive patients with ß-thalassemia, with perihepatic distribution in all patients and paraortic in 74% of them. Abdominal lymphadenopathy in patients with ß-thalassemia who have received multiple transfusions is a rather common imaging finding on sonography, CT, or MRI studies of the upper abdomen. Because this finding is underscored in the literature, it may cause confusion and anxiety in clinicians and patients that then lead to unnecessary investigations. In this study, we present a systematic description of the MRI features of abdominal lymphadenopathy in ß-thalassemia; furthermore, we attempt to explore the relation of lymphadenopathy with posttransfusion chronic hepatitis C and the severity of iron overload.

Abdominal lymphadenopathy has been associated with a variety of pathologic conditions, including lymphoma and metastatic disease, which are the most common, but it has also been associated with benign causes, such as tuberculosis, histiocytosis, sarcoidosis, lymphoproliferative disorders, Whipple's disease, and Crohn's disease [29-31]. Patients with chronic hepatitis C and other chronic liver diseases such as primary biliary sclerosis or sclerosing cholangitis often present with perihepatic lymphadenopathy on cross-sectional imaging studies, whereas enlargement of the retroperitoneal lymph nodes is less common [25, 32-34].

The pathologic conditions, however, are not known to exhibit hypointense lymph nodes on T1- and T2-weighted spin-echo or gradient-echo sequences. Hypointensity of lymph nodes in thalassemic patients who have received multiple transfusions is presumably because of iron deposition in the reticuloendothelial cells of the nodes. To our knowledge, abdominal lymphadenopathy has not been reported in patients with primary hemochromatosis.

The signal intensities of lymph nodes in the thalassemic patients of our study were similar to that of the liver for each individual patient, as shown by the strong correlation between the L/M and LN/M values; this correlation implies that the mechanisms of iron delivery and storage are similar in the liver and lymph nodes. Iron deposition in the spleen did not follow hepatic and lymph node iron overload, as suggested by the lack of correlation between the S/M values and the L/M or LN/M values. The capability of MRI to depict iron deposition in solid viscera may be of value in elucidating the mechanisms of iron distribution in various tissues.

Both posttransfusion chronic hepatitis and the severity of iron overload, as expressed by L/M ratios, seem to contribute to the development of lymphadenopathy. Most of our patients with abdominal lymphadenopathy also had chronic hepatitis C (95%), in contrast to Chu et al. [22] who found that only 32.4% of the thalassemic patients with lymphadenopathy in their study were positive for chronic hepatitis C [22]. Zhang et al. [27] reported that the size, number, and signal intensities of perihepatic enlarged lymph nodes correlated with the severity of hepatic inflammation in patients with chronic hepatitis C and advocated their use as criteria for the activity of hepatic inflammation [27], whereas others have proposed estimation of nodal size with sonography [28]. For the limited number of thalassemic patients with coexistent chronic hepatitis C and available liver biopsy, we found that the size of the abdominal lymph nodes related to the activity level of chronic hepatitis.

A drawback of our study is the lack of histologic findings for the abnormal lymph nodes. Another disadvantage is that thin sections with a smaller field of view were not obtained because MRI examinations aimed to quantify liver iron and to achieve the highest possible signal-to-noise ratios, which scarifies spatial resolution; therefore, estimation of nodal size and signal may not be accurate enough because of partial volume effects, although we have considered the largest node for each patient.

In conclusion, enlarged hypointense lymph nodes in perihepatic and paraortic distributions is a common MRI finding in patients with ß-thalassemia who have received multiple transfusions and have posttransfusion chronic hepatitis C. Although abdominal lymphadenopathy is frequently seen in patients with hepatitis C, hypointense lymph nodes seem to occur only in association with ß-thalassemia. Further studies should verify whether MRI, along with its emerging application as a noninvasive alternative to liver biopsy for the evaluation of liver iron overload, might provide indications with regard to the activity of posttransfusion chronic hepatitis C, which is common in patients with ß-thalassemia who have received multiple transfusions.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Weatherall DJ, Clegg JB, Na-Nakorn S, Wasi P. The pattern of disordered haemoglobin synthesis in homozygous and heterozygous beta-thalassemia. Br J Haematol1969; 16:251 -267[Medline]
  2. Ley TJ, Griffith P, Nienhuis A. Transfusion haemosiderosis and chelation therapy. Clin Haematol1982; 11:437 -464[Medline]
  3. Pippard MJ, Letsky EA, Callender ST, Weatherall DJ. Prevention of iron loading in transfusion dependent thalassemia. Lancet 1978;1:1178 -1181[CrossRef][Medline]
  4. Lucascioli A, Monguzzi W, Tornotti G, et al. Hepatitis virus infection and liver disease in children with thalassemia. Bone Marrow Transplant 1993;12:18 -20[Medline]
  5. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion associated hepatitis C. N Engl J Med1995; 332:1463 -1466[Abstract/Free Full Text]
  6. Barry M, Sherlock S. Measurement of liver iron concentration in needle biopsy specimens. Lancet1971; 1:100 -103[Medline]
  7. de Virgiliis S, Sanna G, Cornarcchia G, et al. Serum ferritin, liver iron stores, and liver histology in children with thalassemia. Arch Dis Child1980; 55:43 -45[Abstract/Free Full Text]
  8. Di Marco V, Lo Iacono O, Almasio P, et al. Long-term efficacy of alpha-interferon a in beta-thalassemics with chronic hepatitis C. Blood 1997;90:2207 -2212[Abstract/Free Full Text]
  9. Gomori JM, Horev G, Tamary H, et al. Hepatic iron overload: quantitative MR imaging. Radiology1991; 179:367 -369[Abstract/Free Full Text]
  10. Papakonstantinou OG, Maris TG, Kostaridou V, et al. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging1995; 13:967 -977[CrossRef][Medline]
  11. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology1994; 193:533 -538[Abstract/Free Full Text]
  12. Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris JC, L'Hermine C. Hepatic iron overload: diagnosis and quantification with MR imaging. AJR1997; 168:1205 -1208[Abstract/Free Full Text]
  13. Fenzi A, Bortolazzi M, Marzola P. Comparison between signal-to-noise ratio, liver-to-muscle ratio and 1/T2 for the non-invasive assessment of liver iron content by MRI. J Magn Reson Imaging 2003;17:589 -592[CrossRef][Medline]
  14. Brittenham GM, Badman DG, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Workshop. Noninvasive measurement of iron: report of an NIDDK workshop. Blood2003; 101:15 -19[Abstract/Free Full Text]
  15. Ooi GC, Khong PL, Chan GC, et al. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassemia patients. Br J Haematol 2004;124:385 -390[CrossRef][Medline]
  16. Alustiza JM, Artexte J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology2004; 230:479 -484[Abstract/Free Full Text]
  17. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J2001; 22:2171 -2179[Abstract/Free Full Text]
  18. Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet2004; 363:357 -362[CrossRef][Medline]
  19. Winchester PH, Cerwin R, Dische R, Canale V. Hemosiderin laden lymph nodes: an unusual roentgenographic manifestation of homozygous thalassemia. Am J Roentgenol Radium Ther Nucl Med1973; 118:222 -226[Medline]
  20. Parsons C. Abdominal lymphography in thalassemia major. Clin Radiol1977; 28:545 -548[CrossRef][Medline]
  21. Mitnick JS, Bosniak MA, Megibow AJ, et al. CT in ß-thalassemia: iron deposition in the liver, spleen, and lymph nodes. AJR 1981;136:1191 -1194[Abstract/Free Full Text]
  22. Chu WC, Metreweli C, Chik KW, Lam WW, Chan YL, Li CK. Enlargement of hepatoduodenal lymph nodes in beta thalassemia children receiving multiple transfusions: a common observation. Haematologica2002; 87:882 -884[Free Full Text]
  23. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology1981; 1:431 -435[Medline]
  24. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology1994; 19:1513 -1520[CrossRef][Medline]
  25. Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP, Baumgartel PB. Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients. Radiology1997; 203:127 -130[Abstract/Free Full Text]
  26. Dorfman RE, Alpern MB, Gross BH, Sander MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology1991; 180:319 -322[Abstract/Free Full Text]
  27. Zhang XM, Mitchell DG, Shi H, et al. Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging. AJR2002; 179:417 -422[Abstract/Free Full Text]
  28. Dietrich CF, Stryjek-Kaminska D, Teuber G, Lee JH, Caspary WF, Zeuzem S. Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection. AJR2000; 174:699 -704[Abstract/Free Full Text]
  29. Kim SY, Kim MJ, Chung JJ, Lee JT, Yoo HS. Abdominal tuberculous lymphadenopathy: MR imaging findings. Abdom Imaging2000; 25:627 -632[CrossRef][Medline]
  30. Avila NA, Ling A, Worobec AS, Mican JM, Metcalfe DD. Systemic mastocytosis: CT and US features of abdominal manifestations. Radiology1997; 202:367 -372[Abstract/Free Full Text]
  31. Warshauer DM, Dumbleton SA, Molina PL, Yankaskas BC, Parker LA, Woosley JT. Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology1994; 192:93 -98[Abstract/Free Full Text]
  32. Gore RM, Vogelzang RL, Nemcek AA Jr. Lymphadenopathy in chronic active hepatitis: CT observations. AJR1988; 151:75 -78[Abstract/Free Full Text]
  33. Blachar A, Federle MP, Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology2001; 220:329 -336[Abstract/Free Full Text]
  34. Casani F, Valentini P, Cataleta M, et al. Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship to viremia. J Hepatol1997; 26:478 -483

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papakonstantinou, O.
Right arrow Articles by Gourtsoyiannis, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papakonstantinou, O.
Right arrow Articles by Gourtsoyiannis, N. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS